200,000+ products from a single source!

sales@angenechem.com

Home > Imidazoles > 100678-32-8

100678-32-8

100678-32-8 | Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:1)

CAS No: 100678-32-8 Catalog No: AG0002M3 MDL No:MFCD00941423

Product Description

Catalog Number:
AG0002M3
Chemical Name:
Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:1)
CAS Number:
100678-32-8
Molecular Formula:
C22H24N2O4
Molecular Weight:
380.4370
MDL Number:
MFCD00941423
IUPAC Name:
butanedioic acid;2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
InChI:
InChI=1S/C18H18N2.C4H6O4/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17;5-3(6)1-2-4(7)8/h1-10,16H,11-13H2,(H,19,20);1-2H2,(H,5,6)(H,7,8)
InChI Key:
XFUIOIWYMHEPIE-UHFFFAOYSA-N
SMILES:
c1ccc(cc1)C1(CC1C1=NCCN1)c1ccccc1.OC(=O)CCC(=O)O

Properties

Complexity:
450  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
380.174g/mol
Formal Charge:
0
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
380.444g/mol
Monoisotopic Mass:
380.174g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
99A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias. The American journal of the medical sciences 20120901
Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation. Internal medicine (Tokyo, Japan) 20120101
Inhibitory effect of cibenzoline on Na+/Ca2+ exchange current in guinea-pig cardiac ventricular myocytes. Journal of pharmacological sciences 20120101
Pharmacodynamics of cibenzoline-induced hypoglycemia in rats. Drug metabolism and pharmacokinetics 20110601
Antiarrhythmic agent cibenzoline attenuates latent obstruction in the left ventricular outflow tract of hypertrophic cardiomyopathy. International journal of cardiology 20110505
Myocardial fibrosis attenuates the effect of cibenzoline on left ventricular diastolic function in patients with hypertrophic cardiomyopathy. Journal of cardiovascular pharmacology 20110201
Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline. The American journal of cardiology 20101101
Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery. Circulation journal : official journal of the Japanese Circulation Society 20100901
Effect of cibenzoline on biventricular pressure gradients in a pediatric patient with hypertrophic obstructive cardiomyopathy. Pediatric cardiology 20100701
Cibenzoline intoxication necessitating implantation of a biventricular assist system in a patient with severe cardiomyopathy. Interactive cardiovascular and thoracic surgery 20100701
Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy. Journal of cardiovascular pharmacology 20100501
Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy. Journal of cardiology 20100101
Quantitative assessment of cibenzoline administration for vagally mediated paroxysmal atrial fibrillation using frequency-domain heart rate variability analysis. Journal of cardiology 20090801
A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation. Journal of cardiology 20090201
Dobutamine stress echocardiography unmasks acute worsening of mitral regurgitation with latent left ventricular outflow tract obstruction behind diastolic heart failure in hypertensive heart disease. Internal medicine (Tokyo, Japan) 20090101
Cibenzoline attenuates systolic anterior motion of the mitral valve after mitral valvoplasty. Journal of anesthesia 20090101
Effect of cibenzoline and atenolol administration on dynamic left ventricular obstruction due to sigmoid-shaped septum. Circulation journal : official journal of the Japanese Circulation Society 20081201
Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm. Circulation journal : official journal of the Japanese Circulation Society 20080501
Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance. Clinical toxicology (Philadelphia, Pa.) 20080401
Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20080301
[Myasthenia-like syndrome induced by cibenzoline overdose in a patient with chronic kidney disease]. Nihon Jinzo Gakkai shi 20080101
Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy: its relationship to transmitral Doppler flow profiles. Circulation journal : official journal of the Japanese Circulation Society 20071001
Quantification of cibenzoline by enzyme-linked immunosorbent assay. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070601
Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy. Heart and vessels 20061101
Cibenzoline attenuates coronary systolic reversal flow in a patient with hypertrophic obstructive cardiomyopathy: a case report. Journal of cardiology 20061001
[Cibenzoline succinate induced pneumonitis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20060710
Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy. Circulation journal : official journal of the Japanese Circulation Society 20060601
Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat. Journal of cardiovascular electrophysiology 20060601
Too little, too late: chasing atrial fibrillation with sodium channel antagonists. Journal of cardiovascular electrophysiology 20060601
Heart failure elevates serum levels of cibenzoline in arrhythmic patients. Circulation journal : official journal of the Japanese Circulation Society 20060501
Relief of left ventricular outflow obstruction by cibenzoline in a patient with Fabry's disease--a case report. Angiology 20060101
Symptomatic hypoglycemia in a patient with chronic hemodialysis. Acta clinica Belgica 20060101
[Coronary vasospasm induced by cibenzoline succinate in a patient with brugada-type electrocardiogram]. Journal of cardiology 20051201
Cibenzoline induced Brugada ECG pattern. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20051101
A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy. European journal of pediatrics 20050801
Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction. Circulation journal : official journal of the Japanese Circulation Society 20050801
Cibenzoline attenuates upregulation of Kv1.5 channel gene expression by experimental paroxysmal atrial fibrillation. International heart journal 20050301
Oral cibenzoline reduces postoperative atrial fibrillation in coronary artery bypass grafting. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20050101
[Cibenzoline-succinate-induced hypoglycemia]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20041010
Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum. Circulation journal : official journal of the Japanese Circulation Society 20041001
Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat. Journal of cardiovascular electrophysiology 20040501
Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline. Heart and vessels 20040501
Cibenzoline therapy for mitral regurgitation in patients with HOCM. Internal medicine (Tokyo, Japan) 20040101
Mitral regurgitation disappearance after cibenzoline treatment in a patient with hypertrophic obstructive cardiomyopathy. Internal medicine (Tokyo, Japan) 20040101
Percutaneous cardiopulmonary support aids resuscitation from sustained ventricular tachycardia. Circulation journal : official journal of the Japanese Circulation Society 20031201
Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline. Circulation journal : official journal of the Japanese Circulation Society 20031001
[A case of acute cibenzoline intoxication in a hemodialysis patient]. Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20030701
Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation. Circulation journal : official journal of the Japanese Circulation Society 20030501
[Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients]. Journal of cardiology 20030401
[Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20030101
Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy. Circulation journal : official journal of the Japanese Circulation Society 20021201
Idiopathic left ventricular aneurysm associated with pleomorphic ventricular tachycardia: a case report. Journal of cardiology 20021201
Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20021001
Extremely prolonged elimination of cibenzoline at toxic plasma concentrations in patients with renal impairments. Therapeutic drug monitoring 20020801
A case of severe respiratory depression due to cibenzoline overdosage induced by a transient renal dysfunction. International journal of cardiology 20020201
[Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation]. Journal of cardiology 20020201
Cibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPase. British journal of pharmacology 20011201
Efficacy of therapeutic drug monitoring in prevention of hypoglycemia caused by cibenzoline. European journal of clinical pharmacology 20011201
Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy. Cardiovascular drugs and therapy 20010901
Cibenzoline has an inhibitory effect on vasorelaxation mediated by adenosine triphosphate-sensitive K(+) channels in the rat carotid artery. Anesthesia and analgesia 20010801
Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy. Japanese circulation journal 20010601
Dual action of ZD6169, a novel K(+) channel opener, on ATP-sensitive K(+) channels in pig urethral myocytes. British journal of pharmacology 20010501
Effects of cibenzoline on cardiac function and metabolism in the rat heart--lung preparation. European journal of anaesthesiology 20010301
Hypoglycemic syncope induced by a combination of cibenzoline and angiotensin converting enzyme inhibitor. Japanese heart journal 20010301
[Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset]. Journal of cardiology 20010201
Blurred vision, left bundle-branch block and cardiac failure. Acta cardiologica 20010201
[Fatal poisoning by cibenzoline]. Therapie 20010101
Choreic movements induced by cibenzoline: an Ic class antiarrhythmic effect? Movement disorders : official journal of the Movement Disorder Society 20000901
[Sudden cardiac arrest after induction of general anesthesia: a case report]. Masui. The Japanese journal of anesthesiology 20000101
Antiarrhythmic effects of optical isomers of cibenzoline on canine ventricular arrhythmias. Journal of cardiovascular pharmacology 19900901
Antiarrhythmic plasma concentrations of cibenzoline on canine ventricular arrhythmias. Journal of cardiovascular pharmacology 19870201

Related Products

© 2019 Angene International Limited. All rights Reserved.